Dorsogluteal vs Ventrogluteal Intramuscular Administration

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to cmichalek@ismp.org. 

1 post / 0 new
Log in or register to post comments
Fri, 02/20/2026 - 10:07
#1
Nicholas Hingle
Nicholas Hingle's picture
Offline
Last seen: 2 days 15 hours ago
Joined: 08/23/2024 - 14:53
Dorsogluteal vs Ventrogluteal Intramuscular Administration

Our health system recently decided to implement a practice change where dorsogluteal injections are no longer allowed. Since then, nursing has reached out on several occasions asking for clarification/confirmation on appropriate, med-specific alternate administration sites. The literature surrounding the risk of adverse events secondary to dorsogluteal administration appears mixed.

Have any sites also implemented such a practice change? If the administration site is not specified in the PI (i.e., directions only mention "intramuscular administration" as opposed to "deltoid," etc.), are you recommending use of ventrogluteal administration?

Top